• Japanese
  • Korean
  • Traditional Chinese
  • Simplified Chinese
Home > Market Research Report > Pharmaceutical > Neurodegenerative Disease

Neurodegenerative Disease Market Research Reports

We offer reports covering rare and common neurodegenerative diseases such as MS, dementia, Alzheimer’s, and epilepsy. Central nervous system drugs are covered individually in the research, which contains information regarding drug pipelines and R&D challenges, as well as assessments of market potential.

New for 2017!
Filter
Title Search
1 - 25 of 261 Products Sort by Display
Central Nervous System Disorder Drugs Markets in China
Published by
Asia Market Information & Development
Product code
100219
Published
May 15, 2017
Content info
214 Pages
Price
USD 4000
Sample available
Alzheimer Disease Drugs Markets in China
Published by
Asia Market Information & Development
Product code
86316
Published
May 15, 2017
Content info
239 Pages
Price
USD 4000
Sample available
Rett Syndrome - Pipeline Review, H1 2017
Published by
Global Markets Direct
Product code
359401
Published
May 9, 2017
Content info
119 Pages
Price
USD 2000
Sample available
Guillain-Barre Syndrome - Pipeline Review, H1 2017
Published by
Global Markets Direct
Product code
332891
Published
May 9, 2017
Content info
46 Pages
Price
USD 2000
Sample available
CNS Cluster Addiction Drug Development Pipeline Review, 2017
Published by
GBI Research
Product code
503690
Published
May 8, 2017
Content info
150 Pages
Price
USD 3995
Sample available
Asperger Syndrome Global Clinical Trials Review, H1, 2017
Published by
GlobalData
Product code
172335
Published
April 26, 2017
Content info
53 Pages
Price
USD 2500
Sample available
*
Published by
Frost & Sullivan
Product code
492209
Published
April 12, 2017
Content info
61 Pages
Price
USD 4950
Sample available
Alcohol Withdrawal Syndrome Global Clinical Trials Review, H1, 2017
Published by
GlobalData
Product code
349788
Published
March 31, 2017
Content info
53 Pages
Price
USD 2500
Sample available
Amnesia Global Clinical Trials Review, H1, 2017
Published by
GlobalData
Product code
305089
Published
March 31, 2017
Content info
50 Pages
Price
USD 2500
Sample available
Agoraphobia Global Clinical Trials Review, H1, 2017
Published by
GlobalData
Product code
304749
Published
March 31, 2017
Content info
57 Pages
Price
USD 2500
Sample available
Amyotrophic Lateral Sclerosis Global Clinical Trials Review, H1, 2017
Published by
GlobalData
Product code
239400
Published
March 31, 2017
Content info
203 Pages
Price
USD 2500
Sample available
Alzheimer's Disease Global Clinical Trials Review, H1, 2017
Published by
GlobalData
Product code
222294
Published
March 31, 2017
Content info
833 Pages
Price
USD 2500
Sample available
Neurodegenerative Disorders Drug Development Pipeline Review, 2017
Published by
GBI Research
Product code
489881
Published
March 21, 2017
Content info
797 Pages
Price
USD 3995
Sample available
Acute Stress Disorder Global Clinical Trials Review, H1, 2017
Published by
GlobalData
Product code
349793
Published
March 15, 2017
Content info
55 Pages
Price
USD 2500
Sample available
Acute Spinal Cord Injury Global Clinical Trials Review, H1, 2017
Published by
GlobalData
Product code
306642
Published
March 15, 2017
Content info
60 Pages
Price
USD 2500
Sample available
Epilepsy - Pipeline Review, H1 2017
Published by
Global Markets Direct
Product code
232793
Published
March 15, 2017
Content info
382 Pages
Price
USD 2000
Sample available
Complex Regional Pain Syndrome - Pipeline Review, H1 2017
Published by
Global Markets Direct
Product code
465218
Published
March 8, 2017
Content info
37 Pages
Price
USD 2000
Sample available
Global Neuropathy Pain Treatment Market 2017-2021
Published by
TechNavio (Infiniti Research Ltd.)
Product code
481449
Published
March 7, 2017
Content info
70 Pages
Price
USD 3500
Sample available
Parkinson's disease forecast and market analysis to 2035
Published by
Datamonitor Healthcare
Product code
365210
Published
March 3, 2017
Content info
299 Pages
Price
USD 22000
Sample available
Lewy Body Dementia in 12 Major Markets 2017-2027
Published by
Black Swan Analysis
Product code
452414
Published
March 1, 2017
Content info
48 pages
Price
USD 6100
Sample available
Alzheimer's Disease in 12 Major Markets 2017-2027
Published by
Black Swan Analysis
Product code
452413
Published
March 1, 2017
Content info
56 pages
Price
USD 6100
Sample available
Global Central Nervous System Partnering 2010-2017: Deal trends, players and financials
Published by
Current Partnering, a division of Wildwood Ventures Limited
Product code
250308
Published
March 1, 2017
Content info
600+ Pages
Price
USD 3495
Sample available
Global Alzheimer's Disease Partnering 2010 to 2017
Published by
Current Partnering, a division of Wildwood Ventures Limited
Product code
239673
Published
March 1, 2017
Content info
100+ Pages
Price
USD 1495
Sample available
Bell's Palsy Forecast in 15 Major Markets 2017-2027
Published by
Black Swan Analysis
Product code
436080
Published
February 7, 2017
Content info
62 Pages
Price
USD 6100
Sample available
NPS+ (EU5) [Parkinson's Disease]
Published by
FirstWord
Product code
488064
Published
February 1, 2017
Content info
 
Price
USD 2575
Sample available